These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12438929)

  • 21. Glucose deprivation increases basal and electrically evoked transmitter release from rat striatal slices. Role of NMDA and adenosine A1 receptors.
    Jin S; Fredholm BB
    Eur J Pharmacol; 1997 Dec; 340(2-3):169-75. PubMed ID: 9537811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat.
    Dora CD; Koch S; Sanchez A; Ruenes G; Liu S; Yezierski RP
    J Neurotrauma; 1998 Jul; 15(7):473-83. PubMed ID: 9674551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological interactions between magnesium ion and adenosine on monoaminergic system in the central nervous system.
    Okada M; Kaneko S
    Magnes Res; 1998 Dec; 11(4):289-305. PubMed ID: 9884987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
    Armstrong S; Ganote CE
    Cardiovasc Res; 1994 Jul; 28(7):1049-56. PubMed ID: 7525060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of adenosine A(2) receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo (13)C MR spectroscopy.
    Hammer J; Qu H; Håberg A; Sonnewald U
    J Neurochem; 2001 Nov; 79(4):885-92. PubMed ID: 11723181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity.
    Boeck CR; Kroth EH; Bronzatto MJ; Vendite D
    Neuropharmacology; 2005 Jul; 49(1):17-24. PubMed ID: 15992577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
    Appel S; Mathôt RA; Langemeijer MW; IJzerman AP; Danhof M
    Br J Pharmacol; 1995 Aug; 115(7):1253-9. PubMed ID: 7582553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine-amino acid interactions in the chick brain: a role in passive avoidance learning.
    Daisley JN; Rose SP
    Brain Res; 1999 Nov; 847(2):149-56. PubMed ID: 10575083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
    Nörenberg W; Wirkner K; Illes P
    Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep.
    Blood AB; Hunter CJ; Power GG
    J Physiol; 2003 Dec; 553(Pt 3):935-45. PubMed ID: 14500776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice.
    Zuchora B; Turski WA; Wielosz M; Urbańska EM
    Neurosci Lett; 2001 Jun; 305(2):91-4. PubMed ID: 11376891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the prejunctional adenosine receptors in the rat anococcygeus muscle.
    Coates J; Green MA; Sheehan MJ; Strong P
    J Pharm Pharmacol; 1994 Nov; 46(11):906-10. PubMed ID: 7897597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
    Kirk IP; Richardson PJ
    Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effect of high glucose against NMDA, free radical, and oxygen-glucose deprivation through enhanced mitochondrial potentials.
    Seo SY; Kim EY; Kim H; Gwag BJ
    J Neurosci; 1999 Oct; 19(20):8849-55. PubMed ID: 10516304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine and caffeine modulate circadian rhythms in the Syrian hamster.
    Antle MC; Steen NM; Mistlberger RE
    Neuroreport; 2001 Sep; 12(13):2901-5. PubMed ID: 11588599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions.
    Zhang D; Xiong W; Albensi BC; Parkinson FE
    J Neurochem; 2011 Jul; 118(1):4-11. PubMed ID: 21395582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purines and neuroprotection.
    Stone TW
    Adv Exp Med Biol; 2002; 513():249-80. PubMed ID: 12575824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
    Pugliese AM; Latini S; Corradetti R; Pedata F
    Br J Pharmacol; 2003 Sep; 140(2):305-14. PubMed ID: 12970092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures.
    Tauskela JS; Comas T; Hewitt K; Monette R; Paris J; Hogan M; Morley P
    Neuroscience; 2001; 107(4):571-84. PubMed ID: 11720781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.